Showing results (1801-1810 of 1,851) with videos related to

Sort By:
Pageof 186
Communications Medicine|March 16, 2023
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adultsAmy C Thomas, Elizabeth Oliver, Holly E Baum, et al.
American Journal of Respiratory Cell and Molecular Biology|May 18, 2026
Upper and Lower Respiratory Tract Compartmentalization in Pediatric Stem Cell TransplantationErica M Evans, Madeline Y Mayday, Emma M Pearce, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Upper and Lower Respiratory Tract Compartmentalization in Pediatric Stem Cell TransplantationErica M Evans, Madeline Y Mayday, Emma M Pearce, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 RearrangementsAshutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 29, 2024
Genomic insights from a deeply phenotyped highly consanguineous neurodevelopmental disorders cohortHosneara Akter, Md Atikur Rahaman, Tamannyat Binte Eshaque, et al.
Scientific Reports|September 23, 2018
Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern NigeriaBrenda A Kwambana-Adams, Rahab C Amaza, Catherine Okoi, et al.
Science (New York, N.Y.)|January 7, 2017
Regeneration of fat cells from myofibroblasts during wound healingMaksim V Plikus, Christian F Guerrero-Juarez, Mayumi Ito, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
The Lancet. Neurology|April 17, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialRabi Tawil, Kathryn R Wagner, Johanna I Hamel, et al.
Nature Communications|January 13, 2023
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammationThiago Moreno L Souza, Vagner D Pinho, Cristina F Setim, et al.
Pageof 186